KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Equity Income (2020 - 2023)

Historic Equity Income for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q4 2023 value amounting to -$1.1 million.

  • Ginkgo Bioworks Holdings' Equity Income fell 11118.66% to -$1.1 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$1.1 million, marking a year-over-year decrease of 11318.49%. This contributed to the annual value of -$2.6 million for FY2023, which is 9397.87% up from last year.
  • According to the latest figures from Q4 2023, Ginkgo Bioworks Holdings' Equity Income is -$1.1 million, which was down 11118.66% from -$67000.0 recorded in Q2 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Equity Income registered a high of $10.0 million during Q4 2022, and its lowest value of -$39.7 million during Q3 2021.
  • For the 4-year period, Ginkgo Bioworks Holdings' Equity Income averaged around -$9.4 million, with its median value being -$4.3 million (2021).
  • Its Equity Income has fluctuated over the past 5 years, first crashed by 1663037.97% in 2021, then surged by 31451.86% in 2022.
  • Quarter analysis of 4 years shows Ginkgo Bioworks Holdings' Equity Income stood at $1.8 million in 2020, then tumbled by 365.7% to -$4.7 million in 2021, then surged by 314.52% to $10.0 million in 2022, then tumbled by 111.19% to -$1.1 million in 2023.
  • Its Equity Income stands at -$1.1 million for Q4 2023, versus -$67000.0 for Q2 2023 and -$1.4 million for Q1 2023.